Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
8-week cohort study of anti-reflux therapy effects on bronchial hyperresponsiveness in reflux-associated chronic cough
2006-004102-13Phase 4Terminated
- Sponsor
- Hull University Teaching Hospitals
- Start
- Sep 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of omeprazole and ranitidine in chronic cough and airway hyperresponsiveness (AHR), sponsored by Hull University Teaching Hospitals. Primary endpoint: Change in methacholine challenge PC20. Started Sep 2006; status: terminated.
02
Drugs
omeprazoleranitidine
03
Conditions
chronic coughairway hyperresponsiveness (AHR)
Beyond the preview
Go deeper on 2006-004102-13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-004102-13.